-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $10

Benzinga·07/30/2026 15:50:56
語音播報
Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $11 to $10.